Cytek Biosciences, Inc. CTKB Product — Total cost of sales
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s product — total cost of sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s product — total cost of sales?
- Cytek Biosciences, Inc. (CTKB) reported product — total cost of sales of $15.92M in Q1 2026.
- How has Cytek Biosciences, Inc.'s product — total cost of sales changed year-over-year?
- Cytek Biosciences, Inc.'s product — total cost of sales increased by 2.5% year-over-year, from $15.53M to $15.92M.
- What is the long-term trend for Cytek Biosciences, Inc.'s product — total cost of sales?
- Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s product — total cost of sales has grown at a 16.9% compound annual growth rate (CAGR), from $37.38M to $69.81M.
- What does product — total cost of sales mean?
- This metric captures the direct costs incurred to manufacture and deliver the company's physical products, including raw materials, labor, and overhead directly attributable to the production process. It is a critical measure for evaluating manufacturing efficiency and the direct profitability of the product segment. Monitoring this cost helps stakeholders understand the impact of supply chain dynamics and production scaling on the company's gross margins.